Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-001349

Chief Executive Officer acquired 900,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2020-01-01 Grant or award +900,000 2,705,237 D: show line 1 in the form
Loading xslF345X03/doc4.xml…